Literature DB >> 19156166

IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patients.

Nicolas Couturier1, Pierre-Antoine Gourraud, Isabelle Cournu-Rebeix, Claire Gout, Florence Bucciarelli, Gilles Edan, Marie-Claude Babron, Françoise Clerget-Darpoux, Michel Clanet, Bertrand Fontaine, David Brassat.   

Abstract

A recent investigation reported, for the first time, an association between variants in the IFIH1-GCA-KCNH7 locus and multiple sclerosis (MS). We sought to replicate this genetic association in MS with a new independent MS cohort composed of French Caucasian MS trio families. The two most significant IFIH1 single nucleotide polymorphisms, rs1990760 and rs2068330, reported as involved in MS susceptibility, were genotyped in 591 French Caucasian MS trio families, and analyzed using the transmission/disequilibrium test. No association with MS was found (rs1990760, P=0.45 and rs2068330, P=0.27). Similarly, no significant association was detected after stratification for HLA-DRB1*1501 carriers. Reasons that may explain this discrepancy between the original report and our study are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19156166      PMCID: PMC2947096          DOI: 10.1038/ejhg.2008.259

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  19 in total

1.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

2.  Population structure, differential bias and genomic control in a large-scale, case-control association study.

Authors:  David G Clayton; Neil M Walker; Deborah J Smyth; Rebecca Pask; Jason D Cooper; Lisa M Maier; Luc J Smink; Alex C Lam; Nigel R Ovington; Helen E Stevens; Sarah Nutland; Joanna M M Howson; Malek Faham; Martin Moorhead; Hywel B Jones; Matthew Falkowski; Paul Hardenbol; Thomas D Willis; John A Todd
Journal:  Nat Genet       Date:  2005-10-09       Impact factor: 38.330

3.  Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies.

Authors:  Andrew D Skol; Laura J Scott; Gonçalo R Abecasis; Michael Boehnke
Journal:  Nat Genet       Date:  2006-01-15       Impact factor: 38.330

4.  Replicating genotype-phenotype associations.

Authors:  Stephen J Chanock; Teri Manolio; Michael Boehnke; Eric Boerwinkle; David J Hunter; Gilles Thomas; Joel N Hirschhorn; Goncalo Abecasis; David Altshuler; Joan E Bailey-Wilson; Lisa D Brooks; Lon R Cardon; Mark Daly; Peter Donnelly; Joseph F Fraumeni; Nelson B Freimer; Daniela S Gerhard; Chris Gunter; Alan E Guttmacher; Mark S Guyer; Emily L Harris; Josephine Hoh; Robert Hoover; C Augustine Kong; Kathleen R Merikangas; Cynthia C Morton; Lyle J Palmer; Elizabeth G Phimister; John P Rice; Jerry Roberts; Charles Rotimi; Margaret A Tucker; Kyle J Vogan; Sholom Wacholder; Ellen M Wijsman; Deborah M Winn; Francis S Collins
Journal:  Nature       Date:  2007-06-07       Impact factor: 49.962

5.  IFIH1-GCA-KCNH7 locus: influence on multiple sclerosis risk.

Authors:  Alfonso Martínez; José Luis Santiago; M Carmen Cénit; Virginia de Las Heras; Hermenegildo de la Calle; Miguel Fernández-Arquero; Rafael Arroyo; Emilio G de la Concha; Elena Urcelay
Journal:  Eur J Hum Genet       Date:  2008-02-20       Impact factor: 4.246

6.  Diagnostic criteria for multiple sclerosis research involving multiply affected families.

Authors:  D E Goodkin; T H Doolittle; S S Hauser; R M Ransohoff; A D Roses; R A Rudick
Journal:  Arch Neurol       Date:  1991-08

Review 7.  Genetic progress towards the molecular basis of autoimmunity.

Authors:  Simon H S Pearce; Tony R Merriman
Journal:  Trends Mol Med       Date:  2006-01-18       Impact factor: 11.951

8.  A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region.

Authors:  Deborah J Smyth; Jason D Cooper; Rebecca Bailey; Sarah Field; Oliver Burren; Luc J Smink; Cristian Guja; Constantin Ionescu-Tirgoviste; Barry Widmer; David B Dunger; David A Savage; Neil M Walker; David G Clayton; John A Todd
Journal:  Nat Genet       Date:  2006-05-14       Impact factor: 38.330

Review 9.  Genetics of multiple sclerosis.

Authors:  David A Dyment; George C Ebers; A Dessa Sadovnick
Journal:  Lancet Neurol       Date:  2004-02       Impact factor: 44.182

Review 10.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Authors:  Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

View more
  4 in total

1.  Carriers of rare missense variants in IFIH1 are protected from psoriasis.

Authors:  Yonghong Li; Wilson Liao; Michele Cargill; Monica Chang; Nori Matsunami; Bing-Jian Feng; Annie Poon; Kristina P Callis-Duffin; Joseph J Catanese; Anne M Bowcock; Mark F Leppert; Pui-Yan Kwok; Gerald G Krueger; Ann B Begovich
Journal:  J Invest Dermatol       Date:  2010-07-29       Impact factor: 8.551

Review 2.  Supramolecular organizing centers at the interface of inflammation and neurodegeneration.

Authors:  Petra Sušjan-Leite; Taja Železnik Ramuta; Elvira Boršić; Sara Orehek; Iva Hafner-Bratkovič
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

Review 3.  Altered Expression of Ion Channels in White Matter Lesions of Progressive Multiple Sclerosis: What Do We Know About Their Function?

Authors:  Francesca Boscia; Maria Louise Elkjaer; Zsolt Illes; Maria Kukley
Journal:  Front Cell Neurosci       Date:  2021-06-25       Impact factor: 5.505

4.  Feature selection based on differentially correlated gene pairs reveals the mechanism of IFN-β therapy for multiple sclerosis.

Authors:  Tao Jin; Chi Wang; Suyan Tian
Journal:  PeerJ       Date:  2020-03-16       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.